Long-term cardiovascular events in individuals hospitalised with COVID-19: a retrospective cohort
Patrícia Soares1,2, Carolina Ruivinho3, Joana Silva4
1National Institute of Health Doutor Ricardo Jorge, Avenida Padre Cruz, Lisbon, 1600-560, Portugal. patseraos@gmail.com.
Insights
Post-COVID condition increases cardiovascular event risk, especially for those with prior heart issues. Vaccination before infection significantly lowered this risk in hospitalized patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Post-COVID condition presents diverse symptoms impacting multiple organ systems.
- Cardiovascular complications are a significant concern in the post-acute phase of COVID-19.
- Limited data exists on cardiovascular event incidence and risk factors post-hospitalization for COVID-19.
Purpose of the Study:
- To determine the incidence of cardiovascular events in patients hospitalized for COVID-19 in Portugal.
- To identify patient and infection-related risk factors for cardiovascular events in the post-acute phase of COVID-19.
Main Methods:
- Registry-based retrospective cohort study involving seven Portuguese hospitals.
- Inclusion of patients hospitalized for COVID-19 between March 2020 and March 2021.
- Analysis of cardiovascular events occurring at least 30 days post-positive SARS-CoV-2 test, considering pre-existing cardiovascular risk and vaccination status.
Main Results:
- 1,803 patients were analyzed; 7.9% experienced at least one cardiovascular event.
- Incidence rate of cardiovascular events was 34.65 per 1,000 person-years.
- Pre-existing cardiovascular risk (aHR: 3.76) increased event risk, while vaccination before SARS-CoV-2 testing (partial aHR: 0.44, complete aHR: 0.46) reduced risk. COVID-19 severity did not significantly impact risk.
Conclusions:
- A significant burden of cardiovascular complications exists post-COVID-19 hospitalization.
- Health services must prepare for screening and preventive measures for high-risk individuals.
- Vaccination prior to COVID-19 infection is associated with a reduced risk of post-acute cardiovascular events.
Background:
Post-COVID condition encompasses a spectrum of persistent or emerging symptoms affecting multiple organ systems, including a heightened risk of cardiovascular complications. Despite growing recognition of this phenomenon, there remains a lack of comprehensive data regarding the incidence and risk factors associated with cardiovascular events during the post-acute phase in patients previously hospitalised for COVID-19. Thus, we aimed to estimate the incidence of cardiovascular events among patients hospitalised for COVID-19 in Portugal and assess the association between patient and infection characteristics and cardiovascular events in the COVID-19 post-acute phase.
Methods:
We conducted a registry-based retrospective cohort study from seven hospitals across Portugal. Data was retrospectively collected from the electronic medical record of each patient. We included individuals hospitalised due to COVID-19 between March 2020 and March 2021. Our outcome of interest was cardiovascular events in the post-acute phase of COVID-19, occurring at least 30 days after a positive SARS-CoV-2 test. The variables of interest considered were the severity of the episode, existing cardiovascular risk and vaccination status before the SARS-CoV-2 test. Person-years was estimated for each individual, and incidence rates were estimated. A Cox proportional hazard regression model was employed to assess risk factors.
Results:
We included 1,803 patients in the analysis, of which 143 (7.9%) experienced at least one cardiovascular event following COVID-19 hospitalisation. The overall incidence rate of having at least one cardiovascular event was 34.65 per 1,000 person-years (95% confidence interval (CI): 29.20; 40.82). We found higher risk of cardiovascular events for individuals with pre-existing cardiovascular risk (adjusted hazard ratio (aHR): 3.76, 95% CI: 1.53; 9.24) and lower risk for individuals with at least one vaccine dose before the SARS-CoV-2 test (partial vaccination - aHR: 0.44, 95%CI: 0.30; 0.64, complete vaccination - aHR: 0.46, 95%CI: 0.2; 0.80). We did not find a significant difference between the severity of the COVID-19 episode and the risk of having cardiovascular events post-COVID-19.
Conclusion:
Our findings suggest a substantial burden of cardiovascular complications post-COVID-19, underscoring the need for health services to be prepared and commence screening and preventive measures for individuals at higher risk.
Related Concept Videos
Longitudinal Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

